Synopsis

Source of validity: Scientific
Rating (out of 5): 4

Alpha phytosterol, like other plant sterols, is supported by scientific evidence for its role in cardiovascular disease management, particularly in lowering cholesterol. Phytosterols are structurally similar to cholesterol and compete with dietary and biliary cholesterol for absorption in the intestines, resulting in reduced blood levels of LDL cholesterol—a major risk factor for atherosclerotic cardiovascular disease. Multiple randomized controlled trials and meta-analyses have demonstrated that daily intake of 2-3 grams of phytosterols can lower LDL cholesterol by approximately 7-12%. This cholesterol-lowering effect is recognized by authoritative bodies such as the American Heart Association and the European Atherosclerosis Society, which recommend phytosterol-enriched foods as part of dietary interventions for hypercholesterolemia. It should be noted that most studies evaluate mixtures of phytosterols (including beta-sitosterol, campesterol, and stigmasterol), and specific data on "alpha phytosterol" as a single entity is limited. However, the term is often used interchangeably or as part of the broader phytosterol category in supplements and functional foods. There is little evidence that phytosterols affect major cardiovascular endpoints (like heart attacks or stroke) directly, but their LDL-lowering effect is well established, and LDL reduction is a validated surrogate marker for cardiovascular risk reduction. Overall, the use of phytosterols to support cardiovascular health is substantiated by a strong body of scientific evidence, especially for cholesterol management.

More about Alpha phytosterol
More about Cardiovascular Disease

Other ingredients used for Cardiovascular Disease

Other health conditions supported by Alpha phytosterol

Products containing Alpha phytosterol